project id: TCGA-ACC; case submitter id: TCGA-OR-A5KO; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.3; age at index: 39; days to birth: -14606; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1970; age at diagnosis: 14606; ajcc clinical m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1414.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1120; initial weight: 80.0; sample id: 1f0390fb-b267-43a2-ba5c-5bb41850e3f8; sample submitter id: TCGA-OR-A5KO-01A; portion id: ff199dc8-78e0-468a-9a2a-fadc98373961; portion submitter id: TCGA-OR-A5KO-01A-11; slide id: 2ec986bb-d9fe-4001-8384-067144e41fb1; slide submitter id: TCGA-OR-A5KO-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 1.0; percent tumor cells: 99.0; percent tumor nuclei: 99.0; section location: TOP;